Meeder Asset Management Inc Aptinyx Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$3.05 - $4.99 $6,682 - $10,933	-2,191 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.81 - $5.03 $4,224 - $11,740	-2,334 Reduced 51.58%	2,191 $5,000
Q4 2019 Feb 13, 2020	BUY	$2.84 - $4.25 $2,005 - $3,000	706 Added 18.49%	4,525 $15,000
Q3 2019 Oct 17, 2019	BUY	$3.0 - $4.08 $7,200 - $9,792	2,400 Added 169.13%	3,819 $13,000
Q2 2019 Aug 05, 2019	BUY	$2.95 - $4.38 $4,186 - $6,215	1,419 New	1,419 $5,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.